Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritis.
作者： Noam Y. Kirson , Sumati Rao , Howard G. Birnbaum , Evan Kantor , Robert S. Wei
DOI: 10.3111/13696998.2013.768530
关键词: Infliximab 、 Dermatology 、 Internal medicine 、 Statistical significance 、 Adalimumab 、 Medicine 、 Etanercept 、 Clinical trial 、 Psoriasis 、 Arthritis 、 Psoriatic arthritis
摘要: AbstractObjectives:No head-to-head trial has compared the efficacy of adalimumab vs etanercept and infliximab for psoriatic arthritis (PsA). This study implements a matching-adjusted indirect comparison technique to address that gap.Methods:Patient-level data from placebo-controlled (ADEPT) were re-weighted match average baseline characteristics pivotal published trials infliximab. ADEPT patients by odds enrollment in comparator trials, estimated using logistic regression. Matched-on included PsA duration, age, gender, severity, active psoriasis, concomitant treatment. After matching, placebo-adjusted treatment arms at weeks 12 (or 14) 24. Outcomes ACR20/50/70, PsARC, HAQ, modified TSS. PASI50/75/90 with psoriasis. Cost per responder (CPR) was assessed US Germany end-points drug list prices. Statistical significance ...
informahealthcare.com参考文章(27)
J A Long, R J Cook, D D Gladman, V T Farewell, J A Husted, Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. The Journal of Rheumatology. ,vol. 24, pp. 511- 517 ,(1997)
K. Lewandowski, M. L. Russell, D. D. Gladman, F. Stafford-Brady, Chi-Hsing Chang, Longitudinal study of clinical and radiological progression in psoriatic arthritis. The Journal of Rheumatology. ,vol. 17, pp. 809- 812 ,(1990)
Katharina B. Sokoll, Philip S. Helliwell, Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. The Journal of Rheumatology. ,vol. 28, pp. 1842- 1846 ,(2001)
James Signorovitch, M. Haim Erder, Jipan Xie, Vanja Sikirica, Mei Lu, Paul S. Hodgkins, Eric Q. Wu, Comparative effectiveness research using matching-adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. Pharmacoepidemiology and Drug Safety. ,vol. 21, pp. 130- 137 ,(2012) , 10.1002/PDS.3246
Mark C Genovese, Philip J Mease, Glen TD Thomson, Alan J Kivitz, Renee J Perdok, Mark A Weinberg, John Medich, Eric H Sasso, M02-570 Study Group, Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy. The Journal of Rheumatology. ,vol. 34, pp. 1040- 1050 ,(2007)
James E. Signorovitch, Eric Q. Wu, Andrew P. Yu, Charles M. Gerrits, Evan Kantor, Yanjun Bao, Shiraz R. Gupta, Parvez M. Mulani, Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept. PharmacoEconomics. ,vol. 28, pp. 935- 945 ,(2010) , 10.2165/11538370-000000000-00000
M Rodgers, D Epstein, L Bojke, H Yang, D Craig, T Fonseca, L Myers, I Bruce, R Chalmers, S Bujkiewicz, M Lai, N Cooper, K Abrams, D Spiegelhalter, A Sutton, M Sculpher, N Woolacott, Etanercept, Infliximab and Adalimumab for the Treatment of Psoriatic Arthritis: A Systematic Review and Economic Evaluation Health Technology Assessment. ,vol. 15, ,(2011) , 10.3310/HTA15100
T. P. SABER, D. J. VEALE, Psoriatic Arthritis Management Update -Biotherapeutic Options The Journal of Rheumatology Supplement. ,vol. 83, pp. 65- 68 ,(2009) , 10.3899/JRHEUM.090229
Ann Cranney, Gordon Guyatt, Lauren Griffith, George Wells, Peter Tugwell, Clifford Rosen, , , Meta-analyses of Therapies for Postmenopausal Osteoporosis. IX: Summary of Meta-Analyses of Therapies for Postmenopausal Osteoporosis Endocrine Reviews. ,vol. 23, pp. 570- 578 ,(2002) , 10.1210/ER.2001-9002
Heiner C. Bucher, Gordon H. Guyatt, Lauren E. Griffith, Stephen D. Walter, The Results of Direct and Indirect Treatment Comparisons in Meta-Analysis of Randomized Controlled Trials Journal of Clinical Epidemiology. ,vol. 50, pp. 683- 691 ,(1997) , 10.1016/S0895-4356(97)00049-8